文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

影响COVID-19体外膜氧合生存的关键特征

Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation.
PubMed 文献 · Crit Care · 2022-06-28
一句话结论COVID-19 ARDS ECMO患者ICU生存率31.4%,高容量ECMO中心、符合改良EOLIA标准、年轻、插管至ECMO时间短与生存相关。

该研究纳入26个中心2020年1月1日至2021年3月22日期间673例COVID-19 ARDS ECMO患者,记录临床特征、辅助治疗、并发症和结局,采用分块logistic回归分析识别与ICU生存相关的变量。总体ICU生存率为31.4%,第二波疫情期间生存率显著更低;符合改良EOLIA标准的284例(42%)患者生存率更高(38%)(p=0.0014,OR 0.64(CI 0.41-0.99))。低、中、高容量中心生存率分别为20%、30%、38%(p=0.0024),高容量中心较低容量中心的OR为0.55(CI 0.28-1.02)。作者认为仔细筛选患者并在高容量ECMO中心治疗与更高的ICU生存 odds 相关。

要点

  • 673例COVID-19 ARDS ECMO患者总体ICU生存率为31.4%,第二波疫情期间生存率显著更低。
  • 符合改良EOLIA标准的284例(42%)患者ICU生存率为38%(p=0.0014,OR 0.64(CI 0.41-0.99))。
  • 低、中、高容量中心ICU生存率分别为20%、30%、38%(p=0.0024),高容量中心较低容量中心OR 0.55(CI 0.28-1.02)。
  • 与生存相关的其他因素包括较年轻、插管至ECMO启动时间较短、BMI>35(相比<25)、未接受肾脏替代治疗或无大出血/血栓栓塞事件。
  • 作者认为仔细筛选患者并在高容量ECMO中心治疗与更高的ICU生存 odds 相关。

适用人群与场景

  • 26个中心2020年1月1日至2021年3月22日期间治疗的673例COVID-19 ARDS ECMO患者。

诊断标准与关键阈值

  • 改良EOLIA标准:284例(42%)患者符合该标准,其ICU生存率为38%(p=0.0014,OR 0.64(CI 0.41-0.99))。

研究设计与关键结果

  • 研究类型:多中心研究,纳入26个中心673例COVID-19 ARDS ECMO患者,采用分块logistic回归分析识别与ICU生存相关的变量。
  • 主要终点:ICU生存率为31.4%;第二波疫情期间生存率显著更低。
  • 符合改良EOLIA标准的284例(42%)患者ICU生存率为38%(p=0.0014,OR 0.64(CI 0.41-0.99))。
  • 低、中、高容量中心ICU生存率分别为20%、30%、38%(p=0.0024);高容量中心较低容量中心OR 0.55(CI 0.28-1.02)。
  • 与生存相关的其他因素:较年轻、插管至ECMO启动时间较短、BMI>35(相比<25)、未接受肾脏替代治疗或无大出血/血栓栓塞事件。

证据类型、等级与局限

  • 证据类型:多中心研究(注册号DRKS00022964,回顾性注册,2020年9月7日)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为仔细筛选患者并在高容量ECMO中心治疗与更高的ICU生存 odds 相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Severe COVID-19 induced acute respiratory distress syndrome (ARDS) often requires extracorporeal membrane oxygenation (ECMO). Recent German health insurance data revealed low ICU survival rates. Patient characteristics and experience of the ECMO center may determine intensive care unit (ICU) survival. The current study aimed to identify factors affecting ICU survival of COVID-19 ECMO patients.

METHODS: 673 COVID-19 ARDS ECMO patients treated in 26 centers between January 1st 2020 and March 22nd 2021 were included. Data on clinical characteristics, adjunct therapies, complications, and outcome were documented. Block wise logistic regression analysis was applied to identify variables associated with ICU-survival.

RESULTS: Most patients were between 50 and 70 years of age. PaO2/FiO2 ratio prior to ECMO was 72 mmHg (IQR: 58-99). ICU survival was 31.4%. Survival was significantly lower during the 2nd wave of the COVID-19 pandemic. A subgroup of 284 (42%) patients fulfilling modified EOLIA criteria had a higher survival (38%) (p = 0.0014, OR 0.64 (CI 0.41-0.99)). Survival differed between low, intermediate, and high-volume centers with 20%, 30%, and 38%, respectively (p = 0.0024). Treatment in high volume centers resulted in an odds ratio of 0.55 (CI 0.28-1.02) compared to low volume centers. Additional factors associated with survival were younger age, shorter time between intubation and ECMO initiation, BMI > 35 (compared to < 25), absence of renal replacement therapy or major bleeding/thromboembolic events.

CONCLUSIONS: Structural and patient-related factors, including age, comorbidities and ECMO case volume, determined the survival of COVID-19 ECMO. These factors combined with a more liberal ECMO indication during the 2nd wave may explain the reasonably overall low survival rate. Careful selection of patients and treatment in high volume ECMO centers was associated with higher odds of ICU survival.

TRIAL REGISTRATION: Registered in the German Clinical Trials Register (study ID: DRKS00022964, retrospectively registered, September 7th 2020, https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022964 .

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Herrmann J, Lotz C, Karagiannidis C, et al. Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation. Crit Care. 2022. PMID: 35765102. doi:10.1186/s13054-022-04053-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。